Intensity Therapeutics Inc
General ticker "INTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $56.3M
Intensity Therapeutics Inc follows the US Stock Market performance with the rate: 6.2%.
Estimated limits based on current volatility of 3.9%: low 4.85$, high 5.24$
Short-term INTS quotes
Long-term INTS plot
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $8.01MM | $7.63MM | $8.32MM |
Operating Income | $-8.01MM | $-7.63MM | $-8.32MM |
Non-Operating Income | $0.12MM | $0.05MM | $-2.22MM |
Interest Expense | $0.02MM | $0.08MM | $0.30MM |
R&D Expense | $5.86MM | $5.13MM | $4.79MM |
Income(Loss) | $-7.90MM | $-7.58MM | $-10.54MM |
Taxes | $-0.00MM | $-0.13MM | $0.00MM |
Profit(Loss) | $-7.89MM | $-7.45MM | $-10.54MM |
Stockholders Equity | $-8.68MM | $-15.10MM | $13.16MM |
Assets | $5.22MM | $1.76MM | $17.30MM |
Operating Cash Flow | $-6.83MM | $-5.48MM | $-7.21MM |
Investing Cash Flow | $0.00MM | $0.00MM | $-6.02MM |
Financing Cash Flow | $2.05MM | $2.25MM | $20.47MM |
Earnings Per Share* | $-0.60 | $-0.57 | $-1.22 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.